MeSH D008223 - lymphoma
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D009370:Neoplasms by histologic type
0 Companies
0 Drugs
Success rate
D008232:Lymphoproliferative disorders
D008223:Â
Lymphoma
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Cytarabine | Cytarabine |  | 1982-01-01 |  |  |
| Cytarabine | Cytosar-u |  | 1998-12-30 |  |  | |
| Prednisone | Prednisone |  | 1982-01-01 |  |  | |
| Thiotepa | Thiotepa |  | 2001-04-20 |  |  | |
| Irinotecan | Irinotecan |  | 2008-02-27 |  |  | |
| Mylan | Cytarabine | Cytarabine |  | 2011-12-13 |  |  |
| Prednisone | Prednisone |  | 1982-01-01 |  |  | |
| Rising Pharmaceuticals | Mitoxantrone | Mitoxantrone |  | 2012-12-11 |  |  |
| Cytarabine | Cytarabine |  | 2011-12-13 |  |  | |
| Prednisone | Prednisone |  | 1982-01-01 |  |  | |
| Sandoz | Prednisone | Prednisone |  | 1982-01-01 |  |  |
| Irinotecan | Irinotecan |  | 2008-02-27 |  |  | |
| Sanofi | Plerixafor | Mozobil |  | 2009-07-30 |  |  |
| Bausch Health Companies | Prednisone | Prednisone |  | 1982-01-01 |  |  |
| Merck Sharp & Dohme | Prednisone | Meticorten |  | 1982-01-01 |  |  |
| Bayer | Prednisone | Deltome |  | 1982-01-01 |  |  |
| Pfizer | Prednisone | Paracort |  | 1982-01-01 |  |  |
| Irinotecan | Camptosar |  | 1996-06-14 |  |  | |
| Aurobindo Pharma | Prednisone | Prednisone |  | 2021-11-16 |  |  |
1
2
3
4
5
6
...
8
>
Clinical Trials
Historical Success Rate
Phase 1
74%193/262
Phase 2
40%118/293
Phase 3
18%32/173
Approved: 10Overall Success rate: 5%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use